Item Type | Name |
Concept
|
Child
|
Concept
|
Child Welfare
|
Concept
|
Child, Preschool
|
Academic Article
|
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
|
Academic Article
|
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
|
Academic Article
|
In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture.
|
Academic Article
|
Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
|
Academic Article
|
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.
|
Academic Article
|
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
|
Academic Article
|
Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth.
|
Academic Article
|
Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections.
|
Academic Article
|
Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children.
|
Academic Article
|
Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents.
|
Academic Article
|
High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).
|
Academic Article
|
Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
|
Academic Article
|
Optimizing frequency of CD4 assays in the era of highly active antiretroviral therapy.
|
Academic Article
|
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
|
Academic Article
|
Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients.
|
Academic Article
|
Retrospective study of the safety of caspofungin in immunocompromised pediatric patients.
|
Academic Article
|
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior.
|
Academic Article
|
Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection.
|
Academic Article
|
Staphylococcus aureus bacteremia in pediatric patients with cancer.
|
Academic Article
|
Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.
|
Academic Article
|
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
|
Academic Article
|
Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer.
|
Academic Article
|
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth.
|
Academic Article
|
Monitoring Central Venous Catheter Resistance to Predict Imminent Occlusion: A Prospective Pilot Study.
|
Academic Article
|
Early patterns of adherence in adolescents initiating highly active antiretroviral therapy predict long-term adherence, virologic, and immunologic control.
|
Academic Article
|
Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.
|
Academic Article
|
Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis.
|
Academic Article
|
Optimum management of pediatric patients with fever and neutropenia.
|
Academic Article
|
Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.
|
Academic Article
|
Effectiveness of varicella vaccine in children infected with HIV.
|
Academic Article
|
Diagnosis and management of central venous catheter-related bloodstream infections in pediatric patients.
|
Academic Article
|
Risk prediction in pediatric cancer patients with fever and neutropenia.
|
Academic Article
|
Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV.
|
Academic Article
|
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza.
|
Academic Article
|
Central line-associated bloodstream infection in children: an update on treatment.
|
Academic Article
|
Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
|
Academic Article
|
Etiology and clinical course of febrile neutropenia in children with cancer.
|
Academic Article
|
A randomized clinical trial of adolescents with HIV/AIDS: pediatric advance care planning.
|
Academic Article
|
Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001.
|
Academic Article
|
Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age.
|
Academic Article
|
Long-term observation of adolescents initiating HAART therapy: three-year follow-up.
|
Academic Article
|
No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line-related bloodstream infection: results of a retrospective matched cohort study and review of the literature.
|
Academic Article
|
The safety of cefepime and ceftazidime in pediatric oncology patients.
|
Academic Article
|
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.
|
Academic Article
|
Efavirenz liquid formulation in human immunodeficiency virus-infected children.
|
Academic Article
|
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.
|
Academic Article
|
Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants.
|
Academic Article
|
Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
|
Academic Article
|
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.
|
Academic Article
|
Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer.
|
Academic Article
|
Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.
|
Academic Article
|
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
|
Academic Article
|
Antiretroviral therapy in HIV-infected infants and children.
|
Academic Article
|
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
|
Academic Article
|
Catheter-Related Complications in Children With Cancer Receiving Parenteral Nutrition: Change in Risk Is Moderated by Catheter Type.
|
Academic Article
|
Manifestations of fungal cellulitis of the orbit in children with neutropenia and fever.
|
Academic Article
|
Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer.
|
Academic Article
|
Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
|
Academic Article
|
Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia.
|
Academic Article
|
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
|
Academic Article
|
A broader look at adolescents with perinatal HIV.
|
Academic Article
|
Increasing the urgency to identify adolescents and young adults with HIV infection…do or die.
|
Academic Article
|
Approaches to accelerating the study of new antiretrovirals in pregnancy.
|